Episode 35: February 6, 2019 - Infiltration: Not What We Thought It Was

Short peripheral catheter (SPC) infiltration: Using technology as another tool to improve patient outcomes.
Commercial Support: ivWatch


Mary Alexander, MA, RN, CRNI®, CAE, FAAN

INS Chief Executive Officer

Mary Alexander, MA, RN, CRNI®, CAE, FAAN, has served as CEO of the Infusion Nurses Society (INS) and Infusion Nurses Certification Corporation, since 1997. She is also editor-in-chief of the Journal of Infusion Nursing, the Core Curriculum for Infusion Nursing, and INS’ textbook, Infusion Nursing: An Evidence-Based Approach. In addition, Mary represented INS on the panel that revised the Centers for Disease Control and Prevention Guidelines for the Prevention of Intravascular Catheter-Related Infections, in 2011. She speaks globally on topics such as the benefits of the specialty practice of infusion nursing, the development of standards of practice, and improving patient safety.

Gary Warren

President and CEO, ivWatch

Gary Warren serves as president and CEO of ivWatch, the only provider of noninvasive continuous monitoring devices for the early detection of peripheral intrvaneous infiltrations and extravastions. In his role, Gary oversees all aspects of operations and strategic direction for the company. He has more than 30 years’ experience with product management and delivery within a range of environments, from small startups to large public companies and government programs. Gary holds a bachelor of science in aeronautical engineering from Embry-Riddle Aeronautical University and a master of science from Mississippi State University in aerospace engineering/computational fluid dynamics. 

About ivWatch: 
ivWatch, LLC is the leading medical device manufacturer and biosensor technology company focused on improving patient safety and the effectiveness of intravenous therapy. Our dedicated and passionate team is focused on our company vision of eliminating patient harm caused by infiltrations and extravasations. Through our innovative monitored IV solutions, we help minimize the risks associated with adverse IV events. Follow us on Twitter @ivWatch or Facebook @ivWatchLLC. www.ivwatch.com

Mary Alexander, MA, RN, CRNI®, CAE, FAAN
Gary Warren, President and CEO of ivWatch 

Even when the most diligent bedside nurse is following SPC assessment protocols, infiltration or extravasation may still occur. This podcast will discuss the various causes of infiltration, and how these events are often based on patient factors such as age, vessel health, and infusate characteristics rather than the result of improper SPC placement. To ensure optimal patient care, infusion nurses and industry partners must continually review available evidence and technological advancements to ensure a given standard or technology supports the best care possible to the patient. Working as a team with clinicians, first-to-market device company ivWatch will share lessons learned about education and improving patient outcomes related to peripheral IV infiltration and extravasation.



Infiltration: Not What We Thought It Was